Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes.

[1]  E. Núñez,et al.  Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels. , 2009, Atherosclerosis.

[2]  Á. Avezum,et al.  Impact of In-Hospital Revascularization on Survival in Patients With Non–ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure , 2008, Circulation.

[3]  A. Tedgui,et al.  Regulatory T‐cell immunity and its relevance to atherosclerosis , 2008, Journal of internal medicine.

[4]  R. Qayyum,et al.  Systematic Review: Comparing Routine and Selective Invasive Strategies for the Acute Coronary Syndrome , 2008, Annals of Internal Medicine.

[5]  T. Heer,et al.  Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. , 2007, European heart journal.

[6]  E. Núñez,et al.  Prognostic differences between routine invasive and conservative strategies for the management of high-risk, non-ST segment acute coronary syndromes: Experience from two consecutive periods in a single center. , 2007, European journal of internal medicine.

[7]  D. Mozaffarian,et al.  The Seattle Heart Failure Model: Prediction of Survival in Heart Failure , 2006, Circulation.

[8]  A. Siegbahn,et al.  FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease , 2005, Heart.

[9]  K. Dickstein,et al.  Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction. , 2005, The American journal of medicine.

[10]  S. Yusuf,et al.  Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2005, JAMA.

[11]  K. Eagle,et al.  Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. , 2005, European heart journal.

[12]  M. Pfeffer,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[13]  Deepak L. Bhatt,et al.  Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative , 2004 .

[14]  M. Bennett,et al.  Role of apoptosis in atherosclerosis and its therapeutic implications. , 2004, Clinical science.

[15]  Robert P. Giugliano,et al.  Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis In Myocardial Infarction 18) Substudy , 2004, Circulation.

[16]  S. Borzak,et al.  Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. , 2003, The American journal of cardiology.

[17]  Deepak L. Bhatt,et al.  Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. , 2003, The American journal of cardiology.

[18]  F. Bruni,et al.  T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction , 2003, Clinical and Experimental Medicine.

[19]  P. Tiberghien,et al.  CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. , 2003, Journal of the American Society of Nephrology : JASN.

[20]  G. Specchia,et al.  Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.

[21]  B. Drénou,et al.  Early Circulating Lymphocyte Apoptosis in Human Septic Shock Is Associated with Poor Outcome , 2002, Shock.

[22]  M. Linton,et al.  B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[23]  K. Fox,et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.

[24]  W Klein,et al.  Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). , 2002, European heart journal.

[25]  R. Schiele,et al.  Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]). , 2001, The American journal of cardiology.

[26]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[27]  G. Specchia,et al.  Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. , 2000, European heart journal.

[28]  J. Kaski,et al.  Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. , 2000, The American journal of cardiology.

[29]  A. Adgey,et al.  Management of acute coronary syndromes , 2000, BMJ : British Medical Journal.

[30]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[31]  R. Gibbons,et al.  Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. , 1997, The American journal of cardiology.

[32]  R. Gibbons,et al.  Incremental Value of the Leukocyte Differential and the Rapid Creatine Kinase-MB Isoenzyme for the Early Diagnosis of Myocardial Infarction , 1995, Annals of Internal Medicine.

[33]  S. Sclarovsky,et al.  Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. , 1994, American heart journal.

[34]  U. Goldbourt,et al.  Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction , 1993 .

[35]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .